Authors:
BROWN PD
JENSEN PO
DIAMANT M
MORTENSEN BT
HOVGAARD D
GIMSING P
NISSEN NI
Citation: Pd. Brown et al., S-PHASE INDUCTION BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA, Leukemia research, 22(11), 1998, pp. 983-989
Citation: Dj. Hovgaard et al., THE IN-VIVO EFFECTS OF INTERLEUKIN-3 ON HISTAMINE LEVELS IN NON-HODGKINS-LYMPHOMA PATIENTS, Pharmacology & toxicology, 80(6), 1997, pp. 290-294
Authors:
BROWN PN
DIAMANT M
OSTRUP P
MORTENSEN BT
HOVGAARD D
GIMSING P
NISSEN NI
JURLANDER J
Citation: Pn. Brown et al., S-PHASE INDUCTION BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 1594-1594
Authors:
BROWN PN
GEISLER CH
MORTENSEN BT
NISSEN NI
Citation: Pn. Brown et al., CELL-CYCLE RECRUITMENT BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3490-3490
Authors:
BROWN PN
HOVGAARD D
REMES K
HOLM M
TEERENHOVI L
ELONEN E
NISSEN NI
Citation: Pn. Brown et al., COMPARISON OF THE EFFICACY AND TOLERANCE OF INTERLEUKIN-3, G-CSF AND GM-CSF FOLLOWING AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY, Blood, 88(10), 1996, pp. 2264-2264
Citation: Dj. Hovgaard et Ni. Nissen, EFFECTS OF INTERLEUKIN-3 FOLLOWING CHEMOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PROSPECTIVE, CONTROLLED PHASE I II STUDY/, European journal of haematology, 54(2), 1995, pp. 78-84
Citation: Dj. Hovgaard et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-3 FOLLOWING CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 91(2), 1995, pp. 367-373
Authors:
HOVGAARD DJ
FOLKE M
MORTENSEN BT
NISSEN NI
Citation: Dj. Hovgaard et al., RECOMBINANT HUMAN INTERLEUKIN-3 - PHARMACOKINETICS AFTER INTRAVENOUS AND SUBCUTANEOUS BOLUS INJECTION AND EFFECTS ON GRANULOCYTE KINETICS, British Journal of Haematology, 87(4), 1994, pp. 700-707
Citation: Pd. Brown et al., TREATMENT WITH CAMPATH-1H ANTIBODY IN PATIENTS WITH RELAPSED NON-HODGKIN-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 84(10), 1994, pp. 10000653-10000653
Authors:
MORTENSEN BT
SCHIFTER S
PEDERSEN LB
JENSEN AN
HOVGAARD D
NISSEN NI
Citation: Bt. Mortensen et al., DEVELOPMENT AND APPLICATION OF A SENSITIVE RADIOIMMUNOASSAY FOR HUMANGRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ABLE TO MEASURE NORMAL CONCENTRATIONS IN BLOOD, Experimental hematology, 21(10), 1993, pp. 1366-1370
Authors:
SHIPP MA
HARRINGTON DP
ANDERSON JR
ARMITAGE JO
BONADONNA G
BRITTINGER G
CABANILLAS F
CANELLOS GP
COIFFIER B
CONNORS JM
COWAN RA
CROWTHER D
DAHLBERG S
ENGELHARD M
FISHER RI
GISSELBRECHT C
HORNING SJ
LEPAGE E
LISTER TA
MEERWALDT JH
MONTSERRAT E
NISSEN NI
OKEN MM
PETERSON BA
TONDINI C
VELASQUEZ WA
YEAP BY
Citation: Ma. Shipp et al., A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 329(14), 1993, pp. 987-994
Citation: D. Hovgaard et Ni. Nissen, IL-3 IN COMBINATION WITH G-CSF OR GM-CSF INDUCES INCREASED BONE-MARROW RECOVERY FOLLOWING CHOP CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000500-10000500